Compare SBFM & NCPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SBFM | NCPL |
|---|---|---|
| Founded | 2006 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3M | 3.2M |
| IPO Year | 2008 | 2022 |
| Metric | SBFM | NCPL |
|---|---|---|
| Price | $1.20 | $0.32 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | ★ 422.8K | 200.4K |
| Earning Date | 04-03-2026 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $36,305,891.00 | $869,460.00 |
| Revenue This Year | $40.47 | $739.37 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 4.11 | N/A |
| 52 Week Low | $0.25 | $0.23 |
| 52 Week High | $3.05 | $2.75 |
| Indicator | SBFM | NCPL |
|---|---|---|
| Relative Strength Index (RSI) | 32.50 | N/A |
| Support Level | $1.13 | N/A |
| Resistance Level | $1.28 | N/A |
| Average True Range (ATR) | 0.15 | 0.00 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 17.02 | 0.00 |
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
Netcapital Inc is a financial technology company. The company facilitates the growth of private companies by providing fundraising services and other consulting services. The company's online private investment platform connects entrepreneurs and investors, enabling companies to raise capital digitally. The Company operates in a single operating segment, which is the provision of fintech services.